RGC
NASD Regencell Bioscience Holdings Ltd.$9.59 ↑ +0.00 (+0.00%) Trading Up from the previous close of $9.59, $0.74 below the day’s high of $10.33
- YTD change
- -54.33%
- vs 20-day SMA
- +39.33%
- vs 200-day SMA
- -48.33%
Price ranges
Price & Performance
-18.51 (-65.87%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 88.5% away from all-time highs of $83.60
- RGC is down 54% since the beginning of the year
- RGC is down 47% over the past 12 months
- RGC is up 61% over the past 1 month
- 1% of all RGC investors are betting against RGC
RGC reads neutral: price sits above one of the two key moving averages, the 12-month move is -43.5%.
- Previous minute
- -$0.00
- Last hour
- +$0.26
- Last 5 days
- +25.69%
- vs 8-day SMA
- +22.97%
No alerts for RGC in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.